Stem Cell Market Size To Reach $15.63 Billion By 2025 | CAGR: 9.2%
The global stem cell market is expected to reach USD 15.63billion by 2025, growing at a CAGR of 9.2%, according to a new report by Grand View Research, Inc. Augmentation in research studies that aim at broadening the utility scope of associated products is anticipated to drive the market growth. These research projects have opened the possibility of implementation of several clinical applications of these cells, thereby impacting disease-modifying treatments.
Scientists are engaged in discovering novel methods to create human stem cells. This is to address the increasing demand for stem cell production for potential investigation in disease management. This factor is certainly expected to accelerate the development of regenerative medicine, thus driving industrial growth.
علاوة على ذلك, cellular therapies are recognized as the next major advancements in transforming healthcare. Firms are expanding their cellular therapy portfolio, understanding the future potential of this arena in the treatment of Parkinson’s disease, type 1 السكري, اصابة الحبل الشوكي, مرض الزهايمر, and others.
في مارس 2016, Scientists at Michigan State University unveiled new kind of cells “induced XEN cells” from a cellular trash pile. This discovery is expected to drive advancements in regenerative medicine. Such discoveries are anticipated to bolster research and sales in this market over the forecast period.
Further key findings from the report suggest:
الخلايا الجذعية البالغة
dominated the market and is expected to maintain its dominance. This can be attributed to the several factors such as lower rejection rates, long term renewal property, and no ethical concerns associated with their usage
Application wise regenerative medicine is estimated to hold the substantial share of the revenue
Presence of significant number pipeline projects for regenerative medicine is expected to fuel growth in the market
فضلاً عن ذلك, exploding research projects have driven the need of harvesting techniques, thereby propelling progress of acquisition technology
Increased R&D activities and huge funds granted by funding bodies to advance cellular research in the U.S. have resulted into the large share of North America
Extensive research carried out in Singapore and Japan is anticipated to drive progress with lucrative avenues
Advanced Cell Technology Inc, Osiris Therapeutics Inc, Celgene Corporation, BIOTIME, INC., Cynata, and STEMCELL Technologies Inc., are some of the major companies operating in this market
A number of stem cells companies
are engaged in seeking investment from overseas organizations and also developing partnerships with the pharmaceutical organizations
Grand View Research has segmented the global stem cells market on the basis of product, application, technology, مُعَالَجَة, and region:
Stem Cell Product Outlook (Revenue, USD Billion, 2014 – 2025)
Adult Stem Cells
Neuronal Stem Cells
الخلايا الجذعية المكونة للدم
الخلايا الجذعية الوسيطة
Umbilical Cord Stem Cells
Others
Human Embryonic Stem Cells
تتضمن الخلايا الجذعية المحفزة
Very Small Embryonic Like Stem Cells
Stem Cell Application Outlook (Revenue, USD Billion, 2014 – 2025)
الطب التجديدي
Neurology
Orthopedics
علم الأورام
Hematology
Cardiovascular and Myocardial Infraction
Injuries
السكري
Liver Disorder
Incontinence
Others
Drug Discovery and Development
Stem Cell Technology Outlook (Revenue, USD Billion, 2014 – 2025)
Cell Acquisition
Bone Marrow Harvest
Umbilical Blood Cord
Apheresis
Cell Production
Therapeutic Cloning
In-vitro Fertilization
Cell Culture
Isolation
الحفظ بالتبريد
Expansion and Sub-Culture
العلاج بالخلايا الجذعية Outlook (Revenue, USD Billion, 2014 – 2025)
To request this report, please contact Dr Eugene Zadorin
( eugene.zadorin@nbscience.com )
